(PDF) On the Role of Melanoma-Specific CD8+ T-Cell Immunity

On the Role of Melanoma-Specific CD8+ T-Cell Immunity in Disease Progression of Advanced-Stage Melanoma Patients

Clinical Cancer Research - United States

doi 10.1158/1078-0432.ccr-04-0260

Full Text

Abstract

Available in full text

Categories

Cancer Research

Date

July 15, 2004

Authors

Publisher

American Association for Cancer Research (AACR)

Related search

A Melanoma Multiepitope Polypeptide Induces Specific CD8+ T-Cell Response

Cellular Immunology

English

Myeloid-Derived Suppressor Cells Are Associated With Disease Progression and Decreased Overall Survival in Advanced-Stage Melanoma Patients

Cancer Immunology, Immunotherapy

Cancer Research

English

Malignant Melanoma and Stage of Disease.

Journal of Clinical Pathology

Forensic Medicine

English

CD8+ T Cell Responses in Metastatic Melanoma Patients Receiving an Adenovirally Antigen Engineered Dendritic Cell Vaccine +/- IFN-α

Journal for ImmunoTherapy of Cancer

Molecular Medicine

Cancer Research

English

Virus-Specific CD8+ T-Cell Responses Better Define HIV Disease Progression Than HLA Genotype

Journal of Virology

English

High Frequency of T Cells Specific for Cryptic Epitopes in Melanoma Patients

English

Preoperative BRAF Inhibition in Patients With Irresectable Locally Advanced Stage III Melanoma

Melanoma Management

English

The Prognostic Role of Circulating CD8+ T Cell Proliferation in Patients With Untreated Extensive Stage Small Cell Lung Cancer

Journal of Translational Medicine

Molecular Biology

English

Melanoma Specific Th1 Cytotoxic T Lymphocyte Lines in Vogt-Koyanagi-Harada Disease.

British Journal of Ophthalmology

Molecular Neuroscience

Sensory Systems

English